{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:49:49Z","timestamp":1793879389562,"version":"4.7.0"},"reference-count":100,"publisher":"Bioscientifica","issue":"4","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":2874,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Venous thromboembolism (VTE) is a serious complication during and after hospitalization, yet is a preventable cause of in-hospital death. Without VTE prophylaxis, the overall VTE incidence in medical and general surgery hospitalized patients is in the range of 10% to 40%, while it ranges up to 40% to 60% in major orthopaedic surgery. With routine VTE prophylaxis, fatal pulmonary embolism is uncommon in orthopaedic patients and the rates of symptomatic VTE within three months are in the range of 1.3% to 10%. VTE prophylaxis methods are divided into mechanical and pharmacological. The former include mobilization, graduated compression stockings, intermittent pneumatic compression device and venous foot pumps; the latter include aspirin, unfractionated heparin, low molecular weight heparin (LMWH), adjusted dose vitamin K antagonists, synthetic pentasaccharid factor Xa inhibitor (fondaparinux) and newer oral anticoagulants. LMWH seems to be more efficient overall compared with the other available agents. We remain sceptical about the use of aspirin as a sole method of prophylaxis in total hip and knee replacement and hip fracture surgery, while controversy still exists regarding the use of VTE prophylaxis in knee arthroscopy, lower leg injuries and upper extremity surgery.<\/jats:p>\n                  <jats:p>Cite this article: EFORT Open Rev 2018;3:130-142. DOI: 10.1302\/2058-5241.3.170018<\/jats:p>","DOI":"10.1302\/2058-5241.3.170018","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T15:54:35Z","timestamp":1524844475000},"page":"136-148","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-16","source":"Crossref","is-referenced-by-count":207,"title":["Thromboembolism prophylaxis in orthopaedics: an update"],"prefix":"10.1530","volume":"3","author":[{"given":"Dimitrios A.","family":"Flevas","sequence":"first","affiliation":[{"name":"First Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayiotis D.","family":"Megaloikonomos","sequence":"additional","affiliation":[{"name":"First Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas","family":"Dimopoulos","sequence":"additional","affiliation":[{"name":"First Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanthia","family":"Mitsiokapa","sequence":"additional","affiliation":[{"name":"First Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayiotis","family":"Koulouvaris","sequence":"additional","affiliation":[{"name":"First Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas F.","family":"Mavrogenis","sequence":"additional","affiliation":[{"name":"First Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"key":"2026070711204748600_bibr1-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(08)60202-0","article-title":"ENDORSE Investigators. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study","volume":"2","author":"Cohen","year":"2008","journal-title":"Lancet"},{"key":"2026070711204748600_bibr2-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/110241501750099258","article-title":"Use of venous thromboembolism prophylaxis for surgical patients: a multicentre analysis of practice in Spain","volume":"167","author":"Otero","year":"2001","journal-title":"Eur J Surg"},{"key":"2026070711204748600_bibr3-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2146\/ajhp060115","article-title":"Hospitals\u2019 compliance with prophylaxis guidelines for venous thromboembolism","volume":"64","author":"Yu","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"2026070711204748600_bibr4-2058-5241.3.170018","first-page":"586","article-title":"Thromboprophylaxis practice patterns in two Western Australian teaching hospitals","volume":"89","author":"Eikelboom","year":"2004","journal-title":"Haematologica"},{"key":"2026070711204748600_bibr5-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/j.1538-7836.2007.02650.x","article-title":"Thromboprophylaxis rates in US medical centers: success or failure?","volume":"5","author":"Amin","year":"2007","journal-title":"J Thromb Haemost"},{"key":"2026070711204748600_bibr6-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1378\/chest.06-2993","article-title":"Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism","volume":"132","author":"Tapson","year":"2007","journal-title":"Chest"},{"key":"2026070711204748600_bibr7-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1160\/TH07-03-0212","article-title":"Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality","volume":"98","author":"Cohen","year":"2007","journal-title":"Thromb Haemost"},{"key":"2026070711204748600_bibr8-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"391S","DOI":"10.1378\/chest.102.4_Supplement.391S","article-title":"Prevention of venous thromboembolism","volume":"102","author":"Clagett","year":"1992","journal-title":"Chest"},{"key":"2026070711204748600_bibr9-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"338S","DOI":"10.1378\/chest.126.3_suppl.338S","article-title":"Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Geerts","year":"2004","journal-title":"Chest"},{"key":"2026070711204748600_bibr10-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/bmj.302.6778.709","article-title":"Incidence of venous thromboembolism verified by necropsy over 30 years","volume":"302","author":"Lindblad","year":"1991","journal-title":"BMJ"},{"key":"2026070711204748600_bibr11-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/014107688908200407","article-title":"Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis?","volume":"82","author":"Sandler","year":"1989","journal-title":"J R Soc Med"},{"key":"2026070711204748600_bibr12-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/jcp.2003.013581","article-title":"Fatal pulmonary embolism in hospitalised patients: a necropsy review","volume":"57","author":"Alikhan","year":"2004","journal-title":"J Clin Pathol"},{"key":"2026070711204748600_bibr13-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.thromres.2016.03.029","article-title":"Worldwide adherence to ACCP guidelines for thromboprophylaxis after major orthopedic surgery: A systematic review of the literature and meta-analysis","volume":"141","author":"Farfan","year":"2016","journal-title":"Thromb Res"},{"key":"2026070711204748600_bibr14-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"I4","DOI":"10.1161\/01.CIR.0000078468.11849.66","article-title":"The epidemiology of venous thromboembolism","volume":"107","author":"White","year":"2003","journal-title":"Circulation"},{"key":"2026070711204748600_bibr15-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3324\/haematol.10516","article-title":"The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients","volume":"92","author":"Prandoni","year":"2007","journal-title":"Haematologica"},{"key":"2026070711204748600_bibr16-2058-5241.3.170018","volume-title":"Prevention and management of venous thromboembolism. SIGN publication no. 122","author":"Scottish Intercollegiate Guidelines Network (SIGN)","year":"2010"},{"key":"2026070711204748600_bibr17-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"I9","DOI":"10.1161\/01.CIR.0000078469.07362.E6","article-title":"Risk factors for venous thromboembolism","volume":"107","author":"Anderson","year":"2003","journal-title":"Circulation"},{"key":"2026070711204748600_bibr18-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2710.2006.00764.x","article-title":"Hospital-acquired venous thromboembolism and prophylaxis in an integrated hospital delivery system","volume":"31","author":"Dorfman","year":"2006","journal-title":"J Clin Pharm Ther"},{"key":"2026070711204748600_bibr19-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"381S","DOI":"10.1378\/chest.08-0656","article-title":"Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition)","volume":"133","author":"Geerts","year":"2008","journal-title":"Chest"},{"key":"2026070711204748600_bibr20-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0020-1383(01)00139-5","article-title":"Changes in coagulability as measured by thrombelastography following surgery for proximal femoral fracture","volume":"32","author":"Wilson","year":"2001","journal-title":"Injury"},{"key":"2026070711204748600_bibr21-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0020-1383(01)00137-1","article-title":"Altered venous function and deep venous thrombosis following proximal femoral fracture","volume":"33","author":"Wilson","year":"2002","journal-title":"Injury"},{"key":"2026070711204748600_bibr22-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/archinte.158.14.1525","article-title":"Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty","volume":"158","author":"White","year":"1998","journal-title":"Arch Intern Med"},{"key":"2026070711204748600_bibr23-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0140-6736(96)01453-5","article-title":"Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo","volume":"348","author":"Planes","year":"1996","journal-title":"Lancet"},{"issue":"1","key":"2026070711204748600_bibr24-2058-5241.3.170018","first-page":"e2","article-title":"American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2012 update: a report from the American Heart Association","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"key":"2026070711204748600_bibr25-2058-5241.3.170018","article-title":"Guidelines for Prevention of Deep Vein Thrombosis in Orthopaedics","author":"Sourmelis","year":"2009"},{"key":"2026070711204748600_bibr26-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1590\/S0102-36162012000600002","article-title":"Prophylaxis of venous thromboembolism in orthopaedic surgery","volume":"47","author":"Leme","year":"2015","journal-title":"Rev Bras Ortop"},{"key":"2026070711204748600_bibr27-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.joon.2003.12.004","article-title":"Venous thromboembolism prevention\u2013an update","volume":"8","author":"Davis","year":"2004","journal-title":"J Orthop Nurs"},{"key":"2026070711204748600_bibr28-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1365-2168.1999.01195.x","article-title":"Graduated compression stockings in the prevention of venous thromboembolism","volume":"86","author":"Agu","year":"1999","journal-title":"Br J Surg"},{"key":"2026070711204748600_bibr29-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1056\/NEJM200012143432403","article-title":"Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty","volume":"343","author":"White","year":"2000","journal-title":"N Engl J Med"},{"key":"2026070711204748600_bibr30-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archinte.1997.00440260055009","article-title":"What is the role of timing in the surgical and rehabilitative care of community-dwelling older persons with acute hip fracture?","volume":"157","author":"Hoenig","year":"1997","journal-title":"Arch Intern Med"},{"key":"2026070711204748600_bibr31-2058-5241.3.170018","first-page":"e278S","article-title":"Prevention of VTE in orthopedic surgery patients: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume-title":"Chest","author":"Falck-Ytter","year":"2012"},{"key":"2026070711204748600_bibr32-2058-5241.3.170018","article-title":"AAOS clinical guideline on preventing venous thrombo- embolic disease in patients undergoing elective hip and knee arthroplasty","author":"Unit","year":"2011"},{"key":"2026070711204748600_bibr33-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"777","DOI":"10.5435\/00124635-201112000-00008","article-title":"AAOS clinical practice guideline: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty","volume":"19","author":"Mont","year":"2011","journal-title":"J Am Acad Orthop Surg"},{"key":"2026070711204748600_bibr34-2058-5241.3.170018","unstructured":"American Academy of Orthopaedic Surgeons. Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. Evidence-based guidelines and evidence report. http:\/\/www.aaos.org\/research\/guidelines\/VTE\/VTE_full_guideline.pdf (date last accessed 11April2017."},{"key":"2026070711204748600_bibr35-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.arth.2016.04.004","article-title":"Aspirin as thromboprophylaxis in hip and knee arthroplasty: a systematic review and meta-analysis","volume":"31","author":"An","year":"2016","journal-title":"J Arthroplasty"},{"key":"2026070711204748600_bibr36-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"160S","DOI":"10.1378\/chest.08-0670","article-title":"Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Ansell","year":"2008","journal-title":"Chest"},{"key":"2026070711204748600_bibr37-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1365-2125.1981.tb01280.x","article-title":"Pharmacokinetics of the enantiomers of acenocoumarol in man","volume":"12","author":"Godbillon","year":"1981","journal-title":"Br J Clin Pharmacol"},{"key":"2026070711204748600_bibr38-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"8S","DOI":"10.1378\/chest.119.1_suppl.8S","article-title":"Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range","volume":"119","author":"Hirsh","year":"2001","journal-title":"Chest"},{"key":"2026070711204748600_bibr39-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"e152S","DOI":"10.1378\/chest.11-2295","article-title":"Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Holbrook","year":"2012","journal-title":"Chest"},{"key":"2026070711204748600_bibr40-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"e24S","DOI":"10.1378\/chest.11-2291","article-title":"Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Garcia","year":"2012","journal-title":"Chest"},{"key":"2026070711204748600_bibr41-2058-5241.3.170018","volume-title":"The heparin-antithrombin system: a natural anticoagulant mechanism","author":"Rosenberg","year":"1994","edition":"3rd ed."},{"key":"2026070711204748600_bibr42-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"141S","DOI":"10.1378\/chest.08-0689","article-title":"Parenteral anticoagulants: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Hirsh","year":"2008","journal-title":"Chest"},{"key":"2026070711204748600_bibr43-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJM198610303151801","article-title":"Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis","volume":"315","author":"Hull","year":"1986","journal-title":"N Engl J Med"},{"key":"2026070711204748600_bibr44-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-0038-1647289","article-title":"Subcutaneous vs intravenous heparin in the treatment of deep venous thrombosis--a randomized clinical trial","volume":"64","author":"Pini","year":"1990","journal-title":"Thromb Haemost"},{"key":"2026070711204748600_bibr45-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/s-0037-1615222","article-title":"The effects of standard and low molecular weight heparin on bone nodule formation in vitro","volume":"80","author":"Bhandari","year":"1998","journal-title":"Thromb Haemost"},{"key":"2026070711204748600_bibr46-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1182\/blood.V86.4.1368.bloodjournal8641368","article-title":"The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvaria","volume":"86","author":"Shaughnessy","year":"1995","journal-title":"Blood"},{"key":"2026070711204748600_bibr47-2058-5241.3.170018","first-page":"75","article-title":"Efficacy and safety of low molecular weight heparin, unfractionated heparin and warfarin for thrombo-embolism prophylaxis in orthopaedic surgery: a meta-analysis of randomised clinical trials","volume":"27","author":"Palmer","year":"1997","journal-title":"Haemostasis"},{"key":"2026070711204748600_bibr48-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1055\/s-0037-1615090","article-title":"Low molecular weight heparin decreases proximal and distal deep venous thrombosis following total knee arthroplasty. A meta-analysis of randomized trials","volume":"79","author":"Howard","year":"1998","journal-title":"Thromb Haemost"},{"key":"2026070711204748600_bibr49-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1302\/0301-620X.82B6.0820795","article-title":"Meta-analysis of thromboembolic prophylaxis after total knee arthroplasty","volume":"82-B","author":"Westrich","year":"2000","journal-title":"J Bone Joint Surg [Br]"},{"key":"2026070711204748600_bibr50-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1054\/arth.2001.21499","article-title":"A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty","volume":"16","author":"Brookenthal","year":"2001","journal-title":"J Arthroplasty"},{"key":"2026070711204748600_bibr51-2058-5241.3.170018","first-page":"CD000305","article-title":"Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures","volume":"4","author":"Handoll","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"2026070711204748600_bibr52-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1538-7836.2004.00757.x","article-title":"Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists: a meta-analysis","volume":"2","author":"Mismetti","year":"2004","journal-title":"J Thromb Haemost"},{"key":"2026070711204748600_bibr53-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1378\/chest.130.3.681","article-title":"How frequently is venous thromboembolism in heparin-treated patients associated with heparin-induced thrombocytopenia?","volume":"130","author":"Levine","year":"2006","journal-title":"Chest"},{"key":"2026070711204748600_bibr54-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin","volume":"332","author":"Warkentin","year":"1995","journal-title":"N Engl J Med"},{"key":"2026070711204748600_bibr55-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1182\/blood-2005-04-1546","article-title":"Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis","volume":"106","author":"Martel","year":"2005","journal-title":"Blood"},{"key":"2026070711204748600_bibr56-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.thromres.2007.02.013","article-title":"Venous thromboembolism after orthopedic surgery: implications of the choice for prophylaxis","volume":"121","author":"Shorr","year":"2007","journal-title":"Thromb Res"},{"key":"2026070711204748600_bibr57-2058-5241.3.170018","first-page":"e44S","article-title":"Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume-title":"Chest","author":"Ageno","year":"2012"},{"key":"2026070711204748600_bibr58-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/1076029616631427","article-title":"Evidence-Based Development and Rationale for Once-Daily Rivaroxaban Dosing Regimens Across Multiple Indications","volume":"22","author":"Kubitza","year":"2016","journal-title":"Clin Appl Thromb Hemost"},{"key":"2026070711204748600_bibr59-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1056\/NEJMoa0800374","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty","volume":"358","author":"Eriksson","year":"2008","journal-title":"N Engl J Med"},{"key":"2026070711204748600_bibr60-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)60880-6","article-title":"Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial","volume":"372","author":"Kakkar","year":"2008","journal-title":"Lancet"},{"key":"2026070711204748600_bibr61-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1056\/NEJMoa076016","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty","volume":"358","author":"Lassen","year":"2008","journal-title":"N Engl J Med"},{"key":"2026070711204748600_bibr62-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(09)60734-0","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial","volume":"373","author":"Turpie","year":"2009","journal-title":"Lancet"},{"key":"2026070711204748600_bibr63-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1538-7836.2004.01100.x","article-title":"A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial","volume":"3","author":"Eriksson","year":"2005","journal-title":"J Thromb Haemost"},{"key":"2026070711204748600_bibr64-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1111\/j.1538-7836.2007.02748.x","article-title":"subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial","volume":"5","author":"Eriksson","year":"2007","journal-title":"J Thromb Haemost"},{"key":"2026070711204748600_bibr65-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archinternmed.2011.1666","article-title":"Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials","volume":"172","author":"Uchino","year":"2012","journal-title":"Arch Intern Med"},{"key":"2026070711204748600_bibr66-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"570","DOI":"10.21037\/cdt.2016.11.17","article-title":"Use of novel oral anticoagulant agents in venous thromboembolism","volume":"6","author":"Madan","year":"2016","journal-title":"Cardiovasc Diagn Ther"},{"key":"2026070711204748600_bibr67-2058-5241.3.170018","unstructured":"Squibb\n              BM.\n            \n          \n          Eliquis (apixaban): US prescribing information. http:\/\/packageinserts.bms.com\/pi\/pi_eliquis.pdf (date last accessed 10April2017)."},{"key":"2026070711204748600_bibr68-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1056\/NEJMoa0810773","article-title":"Apixaban or enoxaparin for thromboprophylaxis after knee replacement","volume":"361","author":"Lassen","year":"2009","journal-title":"N Engl J Med"},{"key":"2026070711204748600_bibr69-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(09)62125-5","article-title":"Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial","volume":"375","author":"Lassen","year":"2010","journal-title":"Lancet"},{"key":"2026070711204748600_bibr70-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa1006885","article-title":"Apixaban versus enoxaparin for thromboprophylaxis after hip replacement","volume":"363","author":"Lassen","year":"2010","journal-title":"N Engl J Med"},{"key":"2026070711204748600_bibr71-2058-5241.3.170018","unstructured":"National Institute for Health and Clinical Excellence. Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. https:\/\/www.nice.org.uk\/guidance\/ng89. Last accessed April5, 2018"},{"key":"2026070711204748600_bibr72-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1302\/2058-5241.2.160083","article-title":"Management of anticoagulation in hip fractures: A pragmatic approach","volume":"2","author":"Yassa","year":"2017","journal-title":"EFORT Open Rev"},{"key":"2026070711204748600_bibr73-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1302\/2058-5241.1.160034","article-title":"Anticoagulation therapy and proximal femoral fracture treatment: an update","volume":"1","author":"Ktistakis","year":"2017","journal-title":"EFORT Open Rev"},{"key":"2026070711204748600_bibr74-2058-5241.3.170018","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN). Management of hip fractures in older people. Edinburgh: SIGN, 2009. http:\/\/www.sign.ac.uk\/pdf\/sign111.pdf Last accessed April5, 2018."},{"key":"2026070711204748600_bibr75-2058-5241.3.170018","unstructured":"British Orthopaedic Association. The care of patients with fragility fracture. http:\/\/www.fractures.com\/pdf\/BOA-BGS-Blue-Book.pdf. Last accessed April5, 2018."},{"key":"2026070711204748600_bibr76-2058-5241.3.170018","first-page":"CD005259","article-title":"Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy","volume":"4","author":"Ramos","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"2026070711204748600_bibr77-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/jth.12283","article-title":"Incidence of venous thromboembolism after elective knee arthroscopic surgery: a historical cohort study","volume":"11","author":"Mauck","year":"2013","journal-title":"J Thromb Haemost"},{"key":"2026070711204748600_bibr78-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMclde1615661","article-title":"Thromboprophylaxis after Knee Arthroscopy","volume":"376","author":"Berger","year":"2017","journal-title":"N Engl J Med"},{"key":"2026070711204748600_bibr79-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.arthro.2015.04.091","article-title":"Incidence and risk factor analysis of symptomatic venous thromboembolism after knee arthroscopy","volume":"31","author":"Krych","year":"2015","journal-title":"Arthroscopy"},{"key":"2026070711204748600_bibr80-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7326\/0003-4819-149-2-200807150-00003","article-title":"Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial","volume":"149","author":"Camporese","year":"2008","journal-title":"Ann Intern Med"},{"key":"2026070711204748600_bibr81-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1056\/NEJMoa1613303","article-title":"Thromboprophylaxis after Knee Arthroscopy and Lower-Leg Casting","volume":"376","author":"van Adrichem","year":"2017","journal-title":"N Engl J Med"},{"key":"2026070711204748600_bibr82-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00068-008-8015-y","article-title":"Insufficient Evidence for Routine Use of Thromboprophylaxis in Ambulatory Patients with an Isolated Lower Leg Injury Requiring Immobilization: results of a Meta-Analysis","volume":"35","author":"Metz","year":"2009","journal-title":"Eur J Trauma Emerg Surg"},{"key":"2026070711204748600_bibr83-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00068-014-0408-5","article-title":"The incidence of deep vein thrombosis and pulmonary embolism following cast immobilisation and early functional bracing of Tendo Achilles rupture without thromboprophylaxis","volume":"41","author":"Heyes","year":"2015","journal-title":"Eur J Trauma Emerg Surg"},{"key":"2026070711204748600_bibr84-2058-5241.3.170018","first-page":"117","article-title":"[Prevention of thrombosis in ambulatory patients]","volume":"22","author":"Reilmann","year":"1993","journal-title":"Orthopade"},{"key":"2026070711204748600_bibr85-2058-5241.3.170018","first-page":"20","article-title":"Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb","volume":"23","author":"Kujath","year":"1993","journal-title":"Haemostasis"},{"key":"2026070711204748600_bibr86-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(95)91320-3","article-title":"Thromboprophylaxis with low-molecular-weight heparin in outpatients with plaster-cast immobilisation of the leg","volume":"346","author":"Kock","year":"1995","journal-title":"Lancet"},{"key":"2026070711204748600_bibr87-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1302\/0301-620X.92B5.23241","article-title":"Venous thromboembolism following prolonged cast immobilisation for injury to the tendo Achillis","volume":"92","author":"Healy","year":"2010","journal-title":"J Bone Joint Surg [Br]"},{"key":"2026070711204748600_bibr88-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1302\/0301-620X.93B4.25731","article-title":"Venous thromboembolic events following foot and ankle surgery in the English National Health Service","volume":"93","author":"Jameson","year":"2011","journal-title":"J Bone Joint Surg [Br]"},{"issue":"12","key":"2026070711204748600_bibr89-2058-5241.3.170018","doi-asserted-by":"crossref","DOI":"10.2106\/JBJS.RVW.O.00012","article-title":"Venous thromboembolic disease in foot and ankle surgery","volume":"3","author":"Guss","year":"2015","journal-title":"JBJS Rev"},{"key":"2026070711204748600_bibr90-2058-5241.3.170018","first-page":"CD006681","article-title":"Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization","volume":"4","author":"Testroote","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2026070711204748600_bibr91-2058-5241.3.170018","first-page":"CD006681","article-title":"Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-limb immobilization","volume":"8","author":"Zee","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2026070711204748600_bibr92-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s11999-011-2166-6","article-title":"Incidence of deep vein thrombosis and pulmonary embolism after Achilles tendon rupture","volume":"470","author":"Patel","year":"2012","journal-title":"Clin Orthop Relat Res"},{"key":"2026070711204748600_bibr93-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00167-015-3976-y","article-title":"Meta-analysis and suggested guidelines for prevention of venous thromboembolism (VTE) in foot and ankle surgery","volume":"24","author":"Calder","year":"2016","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"2026070711204748600_bibr94-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jse.2014.09.025","article-title":"Risk of venous thromboembolism after shoulder arthroplasty in the Medicare population","volume":"24","author":"Day","year":"2015","journal-title":"J Shoulder Elbow Surg"},{"key":"2026070711204748600_bibr95-2058-5241.3.170018","first-page":"281","article-title":"Venous thromboembolism in shoulder surgery: a systematic review","volume":"77","author":"Ojike","year":"2011","journal-title":"Acta Orthop Belg"},{"key":"2026070711204748600_bibr96-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.thromres.2016.03.029","article-title":"Worldwide adherence to ACCP guidelines for thromboprophylaxis after major orthopedic surgery: A systematic review of the literature and meta-analysis","volume":"141","author":"Farfan","year":"2016","journal-title":"Thromb Res"},{"key":"2026070711204748600_bibr97-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1302\/0301-620X.92B9.24765","article-title":"A review of the use of common antiplatelet agents in orthopaedic practice","volume":"92","author":"Dineen","year":"2010","journal-title":"J Bone Joint Surg [Br]"},{"key":"2026070711204748600_bibr98-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Clopidogrel for the reduction of events during observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomised controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"2026070711204748600_bibr99-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/bja\/ael083","article-title":"Coronary artery stenting and non-cardiac surgery--a prospective outcome study","volume":"96","author":"Vicenzi","year":"2006","journal-title":"Br J Anaesth"},{"key":"2026070711204748600_bibr100-2058-5241.3.170018","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12891-016-0988-9","article-title":"Clopidogrel and hip fractures, is it safe? A systematic review and meta-analysis","volume":"17","author":"Soo","year":"2016","journal-title":"BMC Musculoskelet Disord"}],"container-title":["EFORT Open Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/online.boneandjoint.org.uk\/doi\/pdf\/10.1302\/2058-5241.3.170018","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/online.boneandjoint.org.uk\/doi\/full-xml\/10.1302\/2058-5241.3.170018","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.bioscientifica.com\/eor\/article-pdf\/3\/4\/136\/15915\/2058-5241.3.170018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/eor\/article-pdf\/3\/4\/136\/15915\/2058-5241.3.170018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:56:37Z","timestamp":1783439797000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/eor\/article\/3\/4\/136\/2065\/Thromboembolism-prophylaxis-in-orthopaedics-an"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,1]]},"references-count":100,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,27]]},"published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1302\/2058-5241.3.170018","relation":{},"ISSN":["2058-5241"],"issn-type":[{"value":"2058-5241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,1]]}}}